Zambia

Zambia Introduction

Zambia adopted a dual-track framework in May 2021: a Cannabis Act for medicinal/scientific cannabis and an Industrial Hemp Act for low-THC hemp. These enable licensed cultivation, processing, and export, but do not open a domestic recreational market and do not establish a clear retail channel for CBD to local consumers. Enforcement against non-licensed cannabis remains strict.

---

Cannabis & Wellness Regulation Overview

Recreational Cannabis (Adult Use)

Status: Prohibited.

• Possession, sale, and non-licensed cultivation are criminal offenses.
• The 2021 reforms did not authorize adult-use retail or personal possession.

Medical Cannabis

Status: Licensed supply chain for medical/scientific purposes (no public retail).

• The Cannabis Act, 2021 regulates cultivation, manufacture, storage, distribution, import/export under license for medicinal, scientific, or research purposes.
• Licensing, security, and oversight are designated to a Lead Agency named in the Act.
• Domestic patient access via pharmacies/dispensaries has not been formally implemented; current activity is primarily B2B/export.

Hemp Definition & Industrial Use

Status: Licensed industrial hemp (≤0.3% THC).

• The Industrial Hemp Act, 2021 provides licensing for growers, processors, distributors, exporters, and researchers.
• Industrial hemp is defined and regulated separately from medical cannabis; the Cannabis Act excludes plants ≤0.3% THC from its scope.

CBD Products

Status: No specific CBD retail framework.

• CBD is not expressly distinguished from cannabis for domestic consumer sales; local retail authorization is absent.
• CBD activity aligns to licensed medical or industrial channels (often export-oriented).

Cosmetics & Artisanal Products

Status: Restricted.

• Hemp seed oil (no cannabinoids) may be used like other plant oils in cosmetics.
• Cannabinoid-containing ingredients (CBD/THC extracts) are not authorized for cosmetics.
• Standard cosmetic rules apply (safety assessment, labeling in English, importer details).

Functional Mushrooms & Adaptogens

Status: Generally treated as food/supplement ingredients.

• Products must comply with food safety, labeling, and import rules.
• Avoid medical claims; use structure/function or educational language.

Psilocybin / Psychedelics

Status: Prohibited.

• Psilocybin is listed under national controlled-substances legislation; non-authorized activities are illegal.
• Research requires special authorization.

---

Operating Guidance (Hemp Vegan)

Wellness-Driven Coffee & Retail

A conservative, compliant entry path:

• Choose your space: café corner, wellness kiosk, or full retail.
• Start with low-risk SKUs: coffee, superfoods, functional mushrooms, hemp seed foods/cosmetics.
• Phase medical/hemp B2B: partner on licensed cultivation/processing for export while monitoring any opening for local medical dispensing.

Clinical Tools & AI

• Provide educational content and clinical decision support tools in markets with medical activity tied to export.
• Focus on SOPs, documentation, and compliance prompts where patient access may emerge later.

---

Marketing, Claims & Compliance

Advertising & Claims

• No medical claims unless expressly authorized by health regulators.
• Use structure/function or well-sourced educational language.
• Include disclaimers; avoid implying local CBD retail authorization.

Packaging & Labeling

• Food/supplements: ingredient list, allergens, lot, expiry, storage, importer details.
• Cosmetics: INCI names, responsible person/importer, batch, shelf life, warnings as applicable.
• Hemp/CBD exports: match destination-market rules + Zambian export licensing.

---

Taxes, Import & Duties

• VAT: ~16% standard.
• Imports/exports of cannabis/hemp require the relevant licenses/permits under the 2021 Acts and coordination with the designated Lead Agency.
• Expect customs documentation, chain-of-custody, and product testing (THC, contaminants).

---

Risks & Practical Notes

• Recreational: fully prohibited.
• Medical: licensed B2B/export only; no domestic patient retail to date.
• CBD: no standalone retail framework; treat as cannabis unless tied to a license.
• Go-to-market: lead with functional mushrooms, coffee, and hemp seed derivatives; explore licensed hemp/cannabis export partnerships.

---

FAQ (Hemp Vegan)

How does Hemp Vegan help me operate in Zambia?

We map what’s permissible now (functional foods, hemp seed cosmetics), what’s license-dependent (hemp/cannabis cultivation & export), and what’s not allowed (adult-use retail, local CBD consumer sales). We deliver SOPs, training, and vendor playbooks.

Can I sell CBD in stores locally?

Not at this time. There is no dedicated CBD retail authorization; activity is tied to licensed medical/industrial channels and often export-focused.

Is industrial hemp viable?

Yes—licensed hemp ≤0.3% THC is permitted. We support licensing, compliance, and export-ready specifications.

What about psilocybin-assisted services?

Not permitted. Psilocybin remains prohibited except for tightly controlled research.

---

Sources & Review Log

_Last reviewed_: 2025-08-23

• Cannabis Act, 2021 (Act No. 33 of 2021) — medicinal/scientific licensing; excludes plants ≤0.3% THC from scope. :contentReference[oaicite:0]{index=0}
• Industrial Hemp Act, 2021 (Act No. 34 of 2021) — licensing of growers, processors, exporters; industrial hemp framework. :contentReference[oaicite:1]{index=1}
• Narcotic Drugs & Psychotropic Substances Act, 2021 — overarching drug control; enforcement context. :contentReference[oaicite:2]{index=2}
• Pharmacy & Poisons Act (Schedule) — psilocybin scheduled. :contentReference[oaicite:3]{index=3}
• Industry guidance on CBD status (domestic retail not authorized). :contentReference[oaicite:4]{index=4}